AIGH Capital Management’s Biofrontera BFRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$740K Hold
915,210
0.1% 41
2025
Q4
$522K Sell
915,210
-130,840
-13% -$118K 0.13% 33
2025
Q3
$1.03M Buy
1,046,050
+71,525
+7% +$64.8K 0.29% 36
2025
Q2
$693K Buy
974,525
+242,370
+33% +$169K 0.31% 31
2025
Q1
$586K Sell
732,155
-78,942
-10% -$81.2K 0.24% 39
2024
Q4
$884K Buy
811,097
+309,663
+62% +$293K 0.28% 31
2024
Q3
$667K Hold
501,434
0.19% 35
2024
Q2
$450K Hold
501,434
0.14% 36
2024
Q1
$766K Buy
+501,434
New +$695K 0.23% 38

Other funds holding BFRI

AIGH Capital Management's BFRI Position: Q1 2026 in Review

AIGH Capital Management held its Biofrontera (BFRI) position steady in Q1 2026 at 915,210 shares worth $740K. The position accounts for 0.1% of the portfolio, ranked #41.

AIGH Capital Management first reported a position in BFRI in Q1 2024 and has held it in 9 quarters since. The position peaked at $1.03M in Q3 2025. 12 funds tracked by Wall St. Rank hold BFRI as of Q1 2026.

  • AIGH Capital Management held 915,210 shares of Biofrontera worth $740K as of Q1 2026.
  • AIGH Capital Management left its Biofrontera share count unchanged in Q1 2026.
  • Biofrontera made up 0.1% of AIGH Capital Management's portfolio in Q1 2026, its #41 holding.
  • AIGH Capital Management first reported a position in Biofrontera in Q1 2024 and has held it in 9 quarters since.
  • AIGH Capital Management's Biofrontera position peaked at $1.03M in Q3 2025.
  • 12 funds tracked by Wall St. Rank held Biofrontera as of Q1 2026.

Based on AIGH Capital Management's 13F filing for Q1 2026, filed 30 Apr 2026.